IN-DATE
4301-02: Baxter Genzyme Seprafilm Adhesion Barrier: 5" x 6"
Sign in to add this product to your favorites!
| Price: | $2,999.00 $2,699.10 per box of 10 |
|---|---|
| Quantity: | |
| In Stock: | 9 box of 10 |
| Expiration: | 06-2027 |
Related Items
QUICK VIEW
| 5086-02-SD $213.99 EACH Baxter Genzyme Seprafilm Adhesion Barrier Procedure Pack: 3" x 5" (6/PK) Exp: 08-2026 Units in stock: 9 | Order Qty |
|
QUICK VIEW
| 4301-02 $299.00 EACH Baxter Genzyme Seprafilm Adhesion Barrier: 5" x 6" Exp: 02-2027 (or later) Units in stock: 29 | Order Qty |
|
QUICK VIEW
| 5086-02 $799.00 $479.40 EACH Baxter Genzyme Seprafilm Adhesion Barrier Procedure Pack: 3" x 5" (6/PK) Exp: 04-2027 Units in stock: 3 | Order Qty |
QUICK VIEW
| 5086-02 $3,999.00 $2,399.40 per box of 5 Baxter Genzyme Seprafilm Adhesion Barrier Procedure Pack: 3" x 5" (6/PK, 5 PK/BX) Exp: 01-2027 Units in stock: 1 box of 5 | Order Qty |
|
QUICK VIEW
| 4301-02-SD $160.99 EACH Baxter Genzyme Seprafilm Adhesion Barrier: 5" x 6" Exp: 12-2026 Units in stock: 4 | Order Qty |
|
QUICK VIEW
| 6380-01 $175.00 EACH Baxter Genzyme Seprafilm Adhesion Barrier, 4-Section: 3" x 2.5" (4 Membranes per packet) Exp: 08-2027 (or later) Units in stock: 30 | Order Qty |
Additional Details
Baxter Genzyme Seprafilm
SEPRAFILM Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesions between the abdominal wall and the under-lying viscera such as omentum, small bowel, bladder, and stomach, and between the uterus and surrounding structures such as tubes and ovaries, large bowel, and bladder.
AccessGUDID Info
- FDA Product Code: MCN
- FDA Product Code Name: Barrier, absorbable, adhesion
- GMDN Term Code: 34212
- GMDN Term Name: Surgical anti-adhesion material, implantable, bioabsorbable, non-medicated
- GMDN Term Description: A bioabsorbable, surgically-implanted device intended to prevent the abnormal fibrous union (adhesion) between one internal body part/tissue and another following a surgical procedure; neither antimicrobials nor pharmaceuticals are included. It may be supplied as a barrier membrane, hydratable gel, or fluid dressing and is made of appropriate material (e.g., collagen- or hyaluronic acid-based) to reduce adhesion between adjacent anatomical structures.
Manufacturer
Baxter provides a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
